Navigation Links
Novartis Data Shows ACZ885 for Severe Gouty Arthritis Provided Better Pain Relief and Reduced Risk of New Attacks by Up to 68% vs. Steroid
Date:5/24/2011

010, the Group's continuing operations achieved net sales of USD 50.6 billion, while approximately USD 9.1 billion (USD 8.1 billion excluding impairment and amortization charges) was invested in R&D throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 119,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://www.novartis.com.

Novartis is on Twitter. Sign up to follow @Novartis at http://twitter.com/novartis.

References

  1. So A, Alten R, Bardin T, et al. Canakinumab vs triamcinolone in the treatment of acute flares in gouty arthritis patients contraindicated, intolerant and unresponsive to NSAIDs and/or colchicine. Abstract (EULAR11-2483) at: The 2011 Annual European Congress of The European League Against Rheumatism; 2011 May 25-28; London, United Kingdom.
  2. Schlesinger N, Alten R, Bardin T, et al. Efficacy of canakinumab vs triamcinolone acetonide in preventing recurrent flares in acute gouty arthritis patients contraindicated, intolerant or unresponsive to NSAIDs and/or colchicine. Oral presentation (OP0107) at: The 2011 Annual European Congress of The European League Against Rheumatism; 2011 May 25-28; London, United Kingdom.
  3. Schumacher HR Jr. The pathogenesis of gout. Cleve Clin J Med. 2008; 75(5):S2-4.
  4. Annemans l, Spaepen E, Gaskin M, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis. 2008; 67(7):960-6.
  5. Zhu Y, Pandya B, Choi H. Increasing gout prevalence in the US over the last two decades: The National Health and Nutrition Examination Survey (NHANES). Presented at: The American College of Rheumatology Annual Scientific Meeting; 2010 Oct; Atlanta, GA.
  6. Myasoedova E, Crowso
    '/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014  Decision Resources ... market will grow strongly through 2022 at a ... This will be largely supported by strong population ... increase demand for imaging procedures. The Indian government,s ... more facilities to purchase or upgrade diagnostic imaging ...
(Date:8/28/2014)... OSAKA, Japan , Aug. 28, 2014 /PRNewswire/ ... completion of the post-marketing commitment and submissions of ... authorities including the United States ... European Medicines Agency (EMA) and the Japanese Ministry ... Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for ...
(Date:8/28/2014)... SALT LAKE CITY , Aug. 28, 2014 /PRNewswire-iReach/ ... in 2000 by service academy graduates, has published a ... its concentrated, three-day Leadership Excellence Course . In ... the  Leadership Excellence Course to Albuquerque , ... Tucson . Photo - http://photos.prnewswire.com/prnh/20140828/140814 ...
Breaking Medicine Technology:Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 2Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 3Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 2Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 3Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 4Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 5Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 6Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 3Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 4Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 5
... Feb. 17, 2011 Greenway Medical Technologies, Inc., an ... with HP to offer medical practices custom electronic health ... and improve quality of care. Greenway,s ... solution and HP hardware will be available to provide ...
... ATLANTA, Feb. 17, 2011 Ingenious Med, the leading ... its solution is now available on the App Store ... being launched as part of the company,s presence at ... The application enables Ingenious Med,s 9,000 users to access ...
Cached Medicine Technology:Greenway Works With HP to Offer Medical Practices Complete EHR Infrastructure 2Greenway Works With HP to Offer Medical Practices Complete EHR Infrastructure 3Greenway Works With HP to Offer Medical Practices Complete EHR Infrastructure 4HIMSS11: Ingenious Med Launches Billing and Data Capture App for iPhone, iPod touch and iPad 2
(Date:8/29/2014)... 29, 2014 As a chiropractic physician ... understands that there’s a direct connection between the condition ... and back. "Since conventional shoe inserts and orthotics weren’t ... of my own," he said. , Customizable to a ... support for the foot in order to help prevent ...
(Date:8/29/2014)... (HealthDay News) -- Researchers have discovered that people with ... Dyslexia -- the most commonly diagnosed learning disorder in ... writing. Previous research showed that brain activity is ... studies focused only on a small number of brain ... analyze how multiple brain regions use networks to communicate ...
(Date:8/29/2014)... August 29, 2014 Empty Nest ... at http://www.blogtalkradio.com/dr-carol-francis/2014/08/29/psychologist-dr-carol-francis-addressing-empty-nest-syndrome .     , Mothers and fathers, ... money, marital bliss, prodding, laughing and sweating through ... house this week. Relief and parenting pride ... what.” Dr. Carol Francis as a ...
(Date:8/29/2014)... "I have had many hospital stays, including ... many other surgeries in my lifetime, as I am a ... stays, I was unable to move freely in order to ... freely had to physically rotate me every 30 minutes to ... and pulled the sheets. This was jarring and caused me ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Scientists from ... idea that progression-free survival correlates with overall survival of ... the new research. Click here to read it ... The Netherlands studied the cases of 523 mesothelioma ... studies. , “PFSR-18 [progression-free survival at 18 weeks ...
Breaking Medicine News(10 mins):Health News:Scientists Find Differences in Brains of Those With Dyslexia 2Health News:Psychologist Dr. Carol Francis Addressing Empty-Nest Syndrome on Talk Radio Today 2Health News:Psychologist Dr. Carol Francis Addressing Empty-Nest Syndrome on Talk Radio Today 3Health News:InventHelp® Client Develops Equipment for Surgical and Bedridden Patients (HCD-279) 2Health News:European Study Says Disease Progression Predicts Mesothelioma Survival Better Than Treatment Response, According to Surviving Mesothelioma 2
... (HealthDay News) -- New genetic mapping of children with ... gene mutation are particularly well-skilled in the use of ... specific variation of the so-called "PCSK6 gene" and hand-motor ... to suggest that there could be an association between ...
... Japanese research group led by Prof. Ryusuke Kakigi and ... and Prof. Masami K Yamaguchi (Chuo University) found that ... temporal sulcus (STS) when processing positive (happy) and negative ... reported in NeuroImage . Near infrared spectroscopy ...
... , THURSDAY, Nov. 4 (HealthDay News) -- During ... clothes to keep infants warm can lead to dangerous ... syndrome (SIDS), U.S. experts warn. Infants are sensitive ... their body temperature. Research has shown that multiple layers ...
... children, especially those with eczema, are unnecessarily avoiding ... according to researchers at National Jewish Health. The ... children, and is often based primarily on data ... factors, including patient and family history, physical examination, ...
... Cambridge hope to revolutionise cancer therapy after discovering one of ... system to treat cancerous tumours have failed. New ... that a type of stromal cell found in many cancers ... role in suppressing the immune response in cancerous tumours ...
... could help smuggle drugs into the gut, according to ... Journal of Nanotechnology . There are several drugs ... could be targeted at absorption by the lower intestine. ... colon cancer for instance, medication delivered by mouth must ...
Cached Medicine News:Health News:Research Suggests Link Between 'Handedness' and Dyslexia 2Health News:Infants' hemodynamic responses to happy and angry facial expressions 2Health News:Overheating in Infants Can Lead to SIDS, Experts Warn 2Health News:Food-allergy fears drive overly restrictive diets 2Health News:Food-allergy fears drive overly restrictive diets 3Health News:Breakthrough in cancer vaccine research 2Health News:Colonic navigation 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: